Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-25-000285
Filing Date
2025-03-04
Accepted
2025-03-04 18:39:00
Documents
1
Period of Report
2025-03-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 11919
  Complete submission text file 0001593968-25-000285.txt   13330
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 333 NORTH WARREN AVENUE MALVERN PA 19355
Business Address
O'Hara Elaine (Reporting) CIK: 0001968045 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 25707396